Lehman Brothers, Credit Suisse First Boston and Cazenove have succeeded in getting away the huge secondary share sale for Oxford GlycoSciences, the UK biotechnology firm, despite a treacherously difficult market.

Lehman Brothers was sole lead manager and global co-ordinator on the share sale for Oxford Glyco, which was the biggest ever capital raising for a European biotech.